homocysteine has been researched along with Libman-Sacks Disease in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.17) | 18.2507 |
| 2000's | 26 (54.17) | 29.6817 |
| 2010's | 15 (31.25) | 24.3611 |
| 2020's | 5 (10.42) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, XJ; Duan, X; Liu, Y; Wang, L | 1 |
| Afshari, JT; Azarpazhooh, MR; Fard, MH; Rezaieyazdi, Z; Saghafi, M; Salari, M; Sedighi, S; Tabrizi, PS | 1 |
| Li, BZ; Li, XM; Pan, HF; Sam, NB; Wang, DG; Ye, DQ; Zhang, Q | 1 |
| Chang, IJ; Huang, YC; Lee, TH; Tsai, TY; Wang, HH; Yang, TH | 1 |
| Deng, YB; Hu, RT; Huang, JJ; Luo, XP; Nong, SQ; Peng, B; Wang, CF; Wei, WJ; Xiao, SR; Xu, GD | 1 |
| Kane, MA; Li, J; Liu, T; Petri, MA; Stojan, G | 1 |
| Almada, MORDV; Antonini, SRR; Bueno, AC; Coelho-Landell, CA; Czernisz, ÉS; de Carvalho, LM; Ferriani, VPL; Izumi, C; Jordão, AA; Monteiro, JP; Rosa, JC; Salomão, RG | 1 |
| Ray, D; Richardson, BC; Strickland, FM | 1 |
| Belfeki, N; Houman, MH; Khanfir, MS; Said, F | 1 |
| Alarcón, GS; Alfaro-Lozano, JL; Cucho-Venegas, JM; Elera-Fitzcarrald, C; Gamboa-Cárdenas, RV; Iparraguirre-López, H; Medina-Chinchon, M; Pastor-Asurza, CA; Perich-Campos, RA; Pimentel-Quiroz, VR; Reátegui-Sokolova, C; Rodríguez-Bellido, ZJ; Sarmiento-Velasquez, O; Ugarte-Gil, MF; Zeña-Huancas, PA; Zevallos-Miranda, F | 1 |
| Caetano, M; D'Almeida, V; Hilário, MO; Ortiz, TT; Sarni, RO; Souza, FS; Terreri, MT | 1 |
| Ma, KM; Mok, CC; Wong, CK; Ying, SK | 1 |
| Cui, X; Huang, X; Kang, M; Li, S; Shangguan, S; Su, G; Wang, L; Wang, Z; Wu, F; Zhang, T; Zhu, J | 1 |
| Charles-Schoeman, C; Fitzgerald, J; Gorn, A; Grossman, JM; Hahn, BH; Karpouzas, GA; Lourenco, EV; McMahon, M; Ragavendra, N; Sahakian, L; Skaggs, BJ; Taylor, MB; Wallace, DJ; Watson, KE; Weisman, MH; Wong, WK | 1 |
| Díaz-Chamorro, A; Jiménez-Alonso, J; Martinez-Bordonado, J; Navarrete-Navarrete, N; Olvera-Porcel, C; Sabio, JM; Vargas-Hitos, JA; Zamora-Pasadas, M | 1 |
| Díaz-Chamorro, A; Jiménez-Alonso, J; Martinez-Bordonado, J; Navarrete-Navarrete, N; Olvera-Porcel, C; Sabio, JM; Vargas-Hitos, JA; Zamora, M | 1 |
| Cucchiara, AJ; Hammons, AL; Mohr, E; Nackos, E; Summers, CM; Von Feldt, JM; Whitehead, AS | 1 |
| Von Feldt, JM | 1 |
| Huang, WN; Tso, TK | 1 |
| Al, M; Bargman, J; Bradley, T; Ng, L; Silverman, E; Tyrrell, P | 1 |
| Alpert, DR; Cooke, JP; Crow, MK; Devereux, RB; Lockshin, MD; Perna, M; Roman, MJ; Salmon, JE; Sammaritano, L | 1 |
| Fujii, H; Harigae, H; Hirabayashi, Y; Ikeda, T; Ishii, T; Oka, Y | 1 |
| Baker, JF; Cucchiara, A; Lazar, MA; Morales, M; Nackos, E; Qatanani, M; Teff, K; von Feldt, JM | 1 |
| Funakubo Asanuma, Y | 1 |
| Cheng, TT; Chiu, CK | 1 |
| Al-Salem, IH; Al-Salem, MH; Nkansa-Dwamena, D; Refai, TM | 1 |
| de Faire, U; Frostegård, J; Hamsten, A; Jensen-Urstad, K; Silveira, A; Svenungsson, E; Witztum, JL | 1 |
| Chang, NS; Cho, CS; Chung, SY; Kang, MS; Kim, NK; Kim, SH; Na, BW; Oh, D; Park, S | 1 |
| Baumoehl, Y; Caspi, D; Elkayam, O; Habot, B; Leibovitz, A; Levartovsky, D; Litinsky, I; Paran, D; Segal, R; Sela, BA; Wigler, I | 1 |
| Bruce, IN; Gladman, DD; Ibañez, D; Steiner, G; Urowitz, MB | 1 |
| Aguirre, C; Egurbide, MV; Martínez-Berriotxoa, A; Rueda, M; Ruiz-Irastorza, G | 1 |
| Afeltra, A; Amoroso, A; Caccavo, D; Conti, L; Del Porto, F; Ferri, GM; Galluzzo, S; Gandolfo, GM; Mitterhofer, AP; Vadacca, M | 1 |
| Barberis, G; Drenkard, C; Gamron, S; Menso, E; Onetti, CM; Onetti, L; Villafañe, S | 2 |
| Chang, CK; Huang, HY; Huang, WN; Tso, TK | 3 |
| Best, JD; Clemens, L; Dragicevic, G; Godfrey, T; Jenkins, AJ; Karschimkus, CS; Lee, AB; Nikpour, M; Prior, DL; Romas, E; Rowley, KG; Wilson, AM | 1 |
| Chander, A; Cron, RQ; Cucchiara, AJ; Flagg, SD; Gehrie, E; Genin, A; Kealey, C; Morthala, S; Nackos, E; Scalzi, LV; Van Dyke, AL; Von Feldt, JM; Whitehead, AS | 1 |
| Brown, KS; Jensen, LE; Morthala, S; Nackos, E; Von Feldt, JM; Whitehead, AS | 1 |
| Musiał, J; Padjas, A; Swadzba, J; Undas, A | 1 |
| Crow, MK; Davis, A; Devereux, RB; Levine, DM; Lockshin, MD; Paget, SA; Roman, MJ; Salmon, JE; Sammaritano, L | 1 |
| Dyer, AR; Eksarko, P; Lee, C; Pope, RM; Ramsey-Goldman, R; Rhew, EY; Spies, S; Tily, H | 1 |
| Kiani, AN; Magder, L; Petri, M | 1 |
| Dallal, GE; Nadeau, MR; Petri, M; Rosenberg, IH; Roubenoff, R; Selhub, J | 1 |
| De Groot, PG; Derksen, RH; Fijnheer, R; Haas, FJ; Roest, M | 1 |
| Hallegua, DS; Wallace, DJ | 1 |
| Afeltra, A; Amoroso, A; Del Porto, F; Francia, A; Galluzzo, S; Gandolfo, GM; Mitterhofer, AP; Vadacca, M | 1 |
5 review(s) available for homocysteine and Libman-Sacks Disease
| Article | Year |
|---|---|
Serum/plasma homocysteine levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
Topics: Body Mass Index; Case-Control Studies; Homocysteine; Humans; Lupus Erythematosus, Systemic | 2020 |
Serum Homocysteine, Folate, and Vitamin B
Topics: Adult; Folic Acid; Homocysteine; Humans; Lupus Erythematosus, Systemic; Vitamin B 12; Vitamins | 2021 |
Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench.
Topics: Age of Onset; Animals; Atherosclerosis; Biomarkers; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Lupus Erythematosus, Systemic; Rupture; Up-Regulation | 2008 |
[Accelerated atherosclerosis and inflammation in systemic lupus erythematosus].
Topics: C-Reactive Protein; Coronary Artery Disease; Cytokines; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Lipoprotein(a); Lupus Erythematosus, Systemic; Male; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sex Factors | 2012 |
How accelerated atherosclerosis in SLE has changed our management of the disorder.
Topics: Antibodies, Antiphospholipid; Arteriosclerosis; Coronary Disease; Homocysteine; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Risk Factors | 2000 |
1 trial(s) available for homocysteine and Libman-Sacks Disease
| Article | Year |
|---|---|
Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; C-Reactive Protein; Double-Blind Method; Estrogen Antagonists; Female; Follow-Up Studies; Glucocorticoids; Homocysteine; Humans; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Middle Aged; Postmenopause; Prednisolone; Raloxifene Hydrochloride; Severity of Illness Index; Treatment Outcome | 2013 |
42 other study(ies) available for homocysteine and Libman-Sacks Disease
| Article | Year |
|---|---|
[The Correlation Between Serum Hcy Level and Clinical Indicators in Systemic Lupus Erythematosus Patients].
Topics: C-Reactive Protein; Case-Control Studies; Cholesterol; Creatinine; Cystatin C; Homocysteine; Humans; Lupus Erythematosus, Systemic; Triglycerides | 2019 |
Investigation of the Association Between Carotid Artery Intima-Media Thickness (IMT) and Cardiac Risk Factors in Patients with Systemic Lupus Erythematosus.
Topics: Adolescent; Adult; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Cholesterol; Heart Disease Risk Factors; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Triglycerides; Young Adult | 2020 |
Serum Homocysteine Levels and Microalbuminuria in Patient with Systemic Lupus Erythematosus.
Topics: Albuminuria; Homocysteine; Humans; Lupus Erythematosus, Systemic; Retrospective Studies; ROC Curve | 2020 |
Intracellular homocysteine metabolites in SLE: plasma S-adenosylhomocysteine correlates with coronary plaque burden.
Topics: Adult; Aged; Female; Homocysteine; Humans; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine | 2021 |
Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus?
Topics: Adolescent; Anthropometry; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Child; Cross-Sectional Studies; Female; Folic Acid; Glucocorticoids; Homocysteine; Humans; Lipids; Lupus Erythematosus, Systemic; Nutritional Status; Proteomics; Risk Factors; Tumor Necrosis Factor-alpha | 2018 |
Oxidative stress and dietary micronutrient deficiencies contribute to overexpression of epigenetically regulated genes by lupus T cells.
Topics: Adult; Aged; Case-Control Studies; CD4-Positive T-Lymphocytes; Choline; Diet; DNA Methylation; DNA Modification Methylases; Epigenesis, Genetic; Female; Flow Cytometry; Folic Acid; Gene Expression Regulation; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Methionine; Micronutrients; Middle Aged; Oxidative Stress; Peroxynitrous Acid; Riboflavin; T-Lymphocytes; Vitamin B 12; Vitamin B 6; Young Adult; Zinc | 2018 |
[Thrombophilia in systemic lupus erythematosus: A case-control study].
Topics: Activated Protein C Resistance; Adult; Antibodies, Anticardiolipin; beta 2-Microglobulin; Biomarkers; Blood Coagulation Factors; Case-Control Studies; Female; Homocysteine; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Protein C Deficiency; Thrombosis | 2018 |
Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.
Topics: Adult; Disease Progression; Female; Homocysteine; Humans; Immunosuppressive Agents; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Peru; Risk Factors; Severity of Illness Index; Social Class | 2019 |
Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Child; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cysteine; Dyslipidemias; Energy Intake; Female; Folic Acid; Homocysteine; Humans; Lupus Erythematosus, Systemic; Multivariate Analysis; Nutritional Status; Puberty; Risk Factors; Triglycerides; Vitamin B 12; Waist Circumference; Young Adult | 2013 |
Hypomethylation of long interspersed nucleotide element-1 in peripheral mononuclear cells of juvenile systemic lupus erythematosus patients in China.
Topics: Adolescent; Age Factors; Asian People; Case-Control Studies; Child; China; DNA Methylation; Female; Homocysteine; Humans; Leukocytes, Mononuclear; Long Interspersed Nucleotide Elements; Lupus Erythematosus, Systemic; Male; Severity of Illness Index; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
Topics: Adiponectin; Adult; Age Factors; Apolipoprotein A-I; Atherosclerosis; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Cytokine TWEAK; Diabetes Complications; Diabetes Mellitus; Disease Progression; Female; Homocysteine; Humans; Leptin; Longitudinal Studies; Lupus Erythematosus, Systemic; Middle Aged; Multivariate Analysis; Odds Ratio; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tumor Necrosis Factors | 2014 |
Relationship between homocysteine levels and hypertension in systemic lupus erythematosus.
Topics: Adult; Biomarkers; Blood Pressure; Body Mass Index; Case-Control Studies; Chi-Square Distribution; Cross-Sectional Studies; Female; Glucocorticoids; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Linear Models; Logistic Models; Lupus Erythematosus, Systemic; Middle Aged; Multivariate Analysis; Odds Ratio; Prednisone; Prevalence; Pulse Wave Analysis; Risk Factors; Spain; Vascular Stiffness | 2014 |
Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus.
Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Lupus Erythematosus, Systemic; Middle Aged; Pulse Wave Analysis; Vascular Stiffness; Vitamin D; Vitamin D Deficiency | 2015 |
Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Asian; Black or African American; Coronary Artery Disease; Cystathionine beta-Synthase; Enzymes; Female; Ferredoxin-NADP Reductase; Folic Acid; Genotype; Hispanic or Latino; Homocysteine; Humans; Lupus Erythematosus, Systemic; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; White People | 2008 |
Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus.
Topics: Adult; Autoantibodies; Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Female; Fibrinolysis; Heart Rate; Homocysteine; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Oxidative Stress; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Risk Factors; Triglycerides; Up-Regulation | 2009 |
Adipokines as novel biomarkers in paediatric systemic lupus erythematosus.
Topics: Adipokines; Adiponectin; Adolescent; Biomarkers; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Ghrelin; Glucocorticoids; Homocysteine; Humans; Insulin Resistance; Leptin; Lipids; Lupus Erythematosus, Systemic; Male; Prednisone; Severity of Illness Index | 2009 |
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients.
Topics: Adult; Aging; Arginine; Carotid Arteries; Female; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Patient Selection; Prognosis; Severity of Illness Index; Vascular Diseases | 2010 |
A single-stranded DNA-cross-reactive immunogenic epitope of human homocysteine-inducible endoplasmic reticulum protein.
Topics: Animals; Antibodies, Antinuclear; Antibodies, Monoclonal; Apoptosis; Autoantibodies; Cell Line, Tumor; Cross Reactions; DNA; DNA, Single-Stranded; Enzyme-Linked Immunosorbent Assay; Epitope Mapping; Epitopes; HeLa Cells; Homocysteine; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Membrane Proteins; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence | 2011 |
Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification.
Topics: Adult; Biomarkers; Blood Sedimentation; C-Reactive Protein; Calcinosis; Case-Control Studies; Comorbidity; Coronary Artery Disease; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Homocysteine; Humans; Insulin Resistance; Kidney; Logistic Models; Lupus Erythematosus, Systemic; Middle Aged; Resistin; Risk Factors | 2011 |
Elevated homocysteine levels in patients with Raynaud's phenomenon secondary to systemic lupus erythematosus.
Topics: Adult; Cohort Studies; Fasting; Female; Homocysteine; Humans; Lupus Erythematosus, Systemic; Raynaud Disease; Reference Values | 2002 |
Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients.
Topics: Adult; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kuwait; Lupus Erythematosus, Systemic; Male; Risk Factors; Thrombosis | 2002 |
Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease.
Topics: Acute-Phase Reaction; Adult; Arteriosclerosis; Autoantibodies; Cholesterol; Cohort Studies; Echocardiography; Female; Heart Valve Diseases; Homocysteine; Humans; Hypertension, Pulmonary; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Middle Aged; Risk Factors; Triglycerides; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2002 |
Acquired activated protein C resistance, high tissue factor expression, and hyper-homocysteinemia in systemic lupus erythematosus.
Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Prevalence; Retrospective Studies; Thromboembolism; Thromboplastin; Thrombosis | 2003 |
Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cohort Studies; Female; Folic Acid Deficiency; Homocysteine; Humans; Incidence; Israel; Lupus Erythematosus, Systemic; Male; Methylmalonic Acid; Middle Aged; Retrospective Studies; Treatment Outcome; Vitamin B 12; Vitamin B 12 Deficiency | 2004 |
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.
Topics: Adult; Coronary Disease; Female; Homocysteine; Humans; Lipoproteins; Lupus Erythematosus, Systemic; Ontario; Risk; Risk Factors | 2003 |
Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Cholesterol; Creatinine; Female; Folic Acid; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors; Thrombosis; Vitamin B 12 | 2004 |
Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
Topics: Adolescent; Adult; Antibodies, Anticardiolipin; Antithrombins; Female; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Protein C; Prothrombin; Risk Factors; Thrombosis | 2005 |
[Hyperhomocysteine like thrombocytic risk factor in patient with systemic lupus erythematous with antiphospholipid syndrome].
Topics: Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Argentina; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors; Thrombosis; Venous Thrombosis | 2005 |
Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus.
Topics: Adult; Ankle; Arteriosclerosis; Asian People; Blood Flow Velocity; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; Female; Homocysteine; Humans; Lipids; Lupus Erythematosus, Systemic; Male; Middle Aged; Pulsatile Flow; Risk Factors; Thiobarbituric Acid Reactive Substances | 2005 |
A positive correlation between homocysteine and brachial-ankle pulse wave velocity in patients with systemic lupus erythematosus.
Topics: Adult; Ankle; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Atherosclerosis; Blood Flow Velocity; Blood Pressure; DNA; Female; Health Status; Homocysteine; Humans; Lupus Erythematosus, Systemic; Pulsatile Flow; Severity of Illness Index | 2006 |
Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus.
Topics: Adult; Analysis of Variance; Biomarkers; Blood Flow Velocity; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Diastole; Female; Homeostasis; Homocysteine; Humans; Hypertension; Insulin; Insulin Resistance; Interleukin-18; Lipids; Lupus Erythematosus, Systemic; Risk Factors; Statistics, Nonparametric; Triglycerides | 2006 |
Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
Topics: Adult; Arteries; Blood Pressure; Case-Control Studies; CD40 Antigens; Cholesterol, LDL; Coronary Disease; Elasticity; Endothelium, Vascular; Female; Homocysteine; Humans; Logistic Models; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Risk Factors; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 2006 |
Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Topics: Adrenergic beta-Antagonists; Adult; Calcinosis; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Glomerular Filtration Rate; Homocysteine; Humans; Lupus Erythematosus, Systemic; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Regression Analysis; Severity of Illness Index; Tomography, X-Ray Computed | 2006 |
[Hyperhomocystinemia as a thrombotic risk factor in patients suffering from systemic lupus erithematosus and antiphospholipid syndrome].
Topics: Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Argentina; Biomarkers; Case-Control Studies; Chi-Square Distribution; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Pregnancy; Risk Factors; Thrombosis | 2005 |
Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus.
Topics: Adult; Black or African American; Calcinosis; Case-Control Studies; Chemokine CCL2; Coronary Vessels; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Lupus Erythematosus, Systemic; Middle Aged; Nephritis; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; White People | 2007 |
[Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus].
Topics: Adolescent; Adult; Autoantibodies; C-Reactive Protein; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Serum Albumin; Vitamin B 12 | 2007 |
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
Topics: Adult; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors; Ultrasonography | 2007 |
Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus.
Topics: Adult; Bone Density; Case-Control Studies; Female; Follow-Up Studies; Fractures, Bone; Homocysteine; Humans; Lupus Erythematosus, Systemic; Middle Aged; Odds Ratio; Risk Factors | 2008 |
Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
Topics: Adolescent; Adult; Age Factors; Body Mass Index; Calcinosis; Clinical Trials as Topic; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Female; Homocysteine; Humans; Lipoprotein(a); Lupus Erythematosus, Systemic; Male; Middle Aged; Prospective Studies; Risk Factors; Tomography, Spiral Computed | 2008 |
Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.
Topics: Adult; Cerebrovascular Disorders; Female; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Multivariate Analysis; Prospective Studies; Risk Factors; Thrombosis | 1996 |
Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Antibodies, Antiphospholipid; Cohort Studies; Female; Genotype; Heart Diseases; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Retrospective Studies; Thromboembolism | 1998 |
The 677C --> T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in epileptic patients affected by systemic lupus erythematosus.
Topics: Adolescent; Adult; Antibodies, Anticardiolipin; Epilepsy; Female; Gene Expression; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Protein S | 2002 |